Skip to main content
SpringerLink
Log in

Advanced Gastric Cancer: Results of Chemotherapy Trials of the EORTC Gastrointestinal Group

  • Conference paper
Gastric Carcinoma

  • 53 Accesses

Abstract

In the past many patients with advanced gastric cancer were treated with chemotherapy because of the high response rates to combinations that were reported by the end of the 1970s. More recent data from randomized trials, however, have led researchers to question the value of applying combination chemotherapy routinely in advanced disease. Results from phase II and III studies conducted by the EORTC Gastrointestinal Group will be discussed, with implications for current treatment and future studies. Extensive reviews of the literature have been published elsewhere.1,2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. O’Connell MJ: Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol 1985;3:1032.

    PubMed  Google Scholar 

  2. Wils J: Current status of chemotherapy for advanced gastric cancer. Anticancer Res 1987;7:755.

    PubMed  CAS  Google Scholar 

  3. Macdonald JS, Gunderson LL, Cohn I: Cancer of the stomach, in De Vita V, Hellman S, Rosenberg SA (eds): Cancer, Principles and Practice of Oncology. Philadelphia, JB Lippincott, 1982, p 534.

    Google Scholar 

  4. Lacave AJ, Brugarolas A, Buesa JM, et al: Methyl-CCNU (Me), 5-fluorouracil (F), adriamycin (A) (MeFA) versus MeF in advanced gastric cancer, abstract. Proc ASCO 1979;20:310.

    Google Scholar 

  5. Macdonald JS, Woolley PV, Smythe T, et al: 5-Fluorouracil, adriamycin and mitomycin-C treatment of advanced gastric cancer. Cancer 1979;44:42.

    Article  PubMed  CAS  Google Scholar 

  6. The Gastrointestinal Tumor Study Group: Phase II-III chemotherapy studies in advanced gastric cancer. Cancer Treatm Rep 1979;63:1871.

    Google Scholar 

  7. Levi JA, Dailey DN, Aroney RS: Improved combination chemotherapy in advanced gastric cancer. Br Med J 1979;2:1471.

    Article  PubMed  CAS  Google Scholar 

  8. Bitran JD, Desser RK, Koloff MF, et al: Treatment of metastatic pancreatic and gastric adenocarcinoma with 5-fluorouracil, adriamycin and mitomycin C (FAM). Cancer Treatm Rep 1979;63:2049.

    Google Scholar 

  9. Lacave AJ, Wils J, Bleiberg H, et al: An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil and adriamycin in advanced gastric cancer. J Clin Oncol 1987;5:1387.

    PubMed  CAS  Google Scholar 

  10. Lacave AJ, Izarzugaza J, Anton-Aparicio LM, et al: Phase II clinical trial of cisdichlorodiamine platinum in gastric cancer. Am J Clin Oncol 1983;6:35.

    PubMed  CAS  Google Scholar 

  11. Leichman L, McDonald B, Dindogru A, et al: Cisplatin: an active drug in the treatment of disseminated gastric cancer. Cancer 1984;53:18.

    Article  PubMed  CAS  Google Scholar 

  12. Lacave AJ, Wils J, Diaz-Rubio E, et al: Cis-platinum as second-line chemotherapy in advanced gastric carcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Eur J Clin Oncol 1985;21:1321.

    Article  CAS  Google Scholar 

  13. Klein HO, Dias Wickramanayake P, Dieterle F, et al: Chemotherapie-protokoll zur Behandlung des metastasierenden Magenkarzinoms. Methotrexat, Adriamycin and 5-Fluorouracil. Dtsch Med Wschr 1982;45:1708.

    Article  Google Scholar 

  14. Klein HO, Dias Wickramanayake P, Farrokh G-H: 5-Fluorouracil (5-FU), adriamycin (ADM) and methotrexate (MTX) -a combination protocol (FAMTX) for treatment of metastasized stomach cancer, abstract. Proc ASCO 1986;5:84.

    Google Scholar 

  15. Wils J, Bleiberg H, Blijham G, et al: An EORTC gastrointestinal group evaluation of the combination of sequential methotrexate (MTX) and 5-fluorouracil (F), combined with adriamycin (A) (FAMTX) in advanced measurable gastric cancer. J Clin Oncol 1986;4:1799.

    PubMed  CAS  Google Scholar 

  16. Blijham G, Herrmann R, Neijt JP, et al: Background for and progress of an ongoing EORTC phase II study, abstract. Proc EORTC Symp on Gastrointest Cancer Update on Comb Modal Ther, Heidelberg, 1986.

    Google Scholar 

  17. Bruckner HW, Stablein DM: Single arm trials of triazinate, cisplatin and methotrexate combinations in advanced gastric cancer, abstract. Proc ASCO 1984;3:144.

    Google Scholar 

  18. Muro H, Romera Acuna L, Castagnari A, et al: Sequential methotrexate, 5-fluorouracil (high dose), and doxorubicin for advanced gastric cancer. Cancer Treatm Rep 1986;70:1333.

    CAS  Google Scholar 

  19. Ajani J, Levin B, Goudeau P, et al: Adriamycin with sequential methotrexate and 5-fluorouracil (AMF) for advanced gastric cancer, abstract. Proc ASCO 1986;5:93.

    Google Scholar 

  20. Macdonald JS, Schein PS, Woolley PV, et al: 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980;93:533.

    PubMed  CAS  Google Scholar 

  21. Anderson JR, Cain KC, Gelber RD: Analysis of survival by tumor response. J Clin Oncol 1983;1:710.

    PubMed  CAS  Google Scholar 

  22. The Gastrointestinal Tumor Study Group: A comparative clinical assessment of combination chemotherapy in advanced gastric carcinoma. Cancer 1982;49:1362.

    Article  Google Scholar 

  23. The Gastrointestinal Tumor Study Group: Randomized study of combination chemotherapy in unresectable gastric cancer. Cancer 1984;53:13.

    Article  Google Scholar 

  24. Panettiere FJ, Haas C, McDonald B, et al: Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study. J Clin Oncol 1984;2:420.

    PubMed  CAS  Google Scholar 

  25. Haas C, Oistri N, McDonald B, et al: Southwest Oncology Group phase II-III gastric cancer study: 5-Fluorouracil, adriamycin and mitomycin-C + vincristine (FAM vs VFAM) compared to chlorozotocin (CZT), m-AMSA and dihydroxyanthracenedine (DHAD) with unimpressive differences, abstract. Proc ASCO 1983;2:122.

    Google Scholar 

  26. Douglass HO, Lavin PT, Goudsmit A, et al: An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin-C, adriamycin and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). J Clin Oncol 1984;2:1372.

    PubMed  Google Scholar 

  27. Cullinan SA, Moertel CG, Fleming TR, et al: A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin and mitomycin. JAMA 1985;253:2061.

    Google Scholar 

  28. De Lisi V, Cocconi G, Tonato M, et al: Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin and mitomycin (BAFMi) in the treatment of advanced gastric cancer. A phase III trial of the Italian Clinical Research Oncology Group (GOIRC). Cancer Treatm Rep 1986;70:481.

    Google Scholar 

  29. Woolley PV, Smith F, Estevez R, et al: A phase II trial of 5-FU, adriamycin and cisplatin (FAP) in advanced gastric cancer, abstract. Proc ASCO 1981;22:455.

    Google Scholar 

  30. Vogl SE, Engstrom PF: Cisplatin, doxorubicin and 5-FU in combination for advanced gastric cancer. Cancer Treatm Rep 1984;68:1273.

    CAS  Google Scholar 

  31. Wagener DJTh, Yap SH, Wobbes Th, et al: Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer. Cancer Chemother Pharmacol 1985;15:86.

    Article  PubMed  CAS  Google Scholar 

  32. Moertel CG, Rubin J, O’Connell MJ, et al: A phase II study of combined 5-fluorouracil, doxorubicin and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol 1986;4:1053.

    PubMed  CAS  Google Scholar 

  33. Rougier Ph, Droz JP, Piot G, et al: Phase II trial of combined 5-FU-adriamycincisplatin (FAP) in gastric carcinoma, abstract. Cancer Chemother Pharmacol 1986; 18(suppl 1):62.

    Google Scholar 

  34. Tagliagambe A, Lombardi M, Troiana R, et al: FAP regimen in advanced gastric cancer, abstract. Cancer Chemother Pharmacol 1986;18(suppl 1):67.

    Google Scholar 

  35. Bruckner HW, Stablein DM: A randomized study of 5-fluorouracil (F) and doxorubicin (A) with semustine (Me), cisplatin (P), or triazinate (T) for treatment of advanced gastric cancer, abstract. Proc ASCO 1986;5:90.

    Google Scholar 

  36. Lacave AJ, Anton-Aparicio L, Gonzales-Baron M, et al: Cisplatin and 5-fluorouracil (5FU) 120-hr infusion for advanced gastric cancer (GC): A phase II multicenter study, abstract. Proc ASCO 1987;6:91.

    Google Scholar 

  37. Preusser P, Wilke H, Achterrath W, et al: Advanced gastric carcinoma: A phase II study with etoposide (E), adriamycin (A) and split course cisplatin (P) = EAP, abstract. Proc ASCO 1987;6:75.

    Google Scholar 

  38. Killen JY, Ellenberg SS, Friedman MA: Combination chemotherapy (CT) regimens in advanced gastric cancer (GC), abstract. Proc ASCO 1985;4:82.

    Google Scholar 

Download references

Authors
  1. J. A. Wils
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Gastroenterology and Oncology, General Hospital, Celle, Germany

    Jürgen Hotz M.D. (Professor of Medicine, Head) (Professor of Medicine, Head)

  2. Department of Surgery, Division of Abdominal and Transplantation Surgery, Medical University of Hannover, Hannover, Germany

    Hans-Joachim Meyer M.D. (Professor of Surgery) (Professor of Surgery)

  3. Department of Hematology/Oncology, Medical University of Hannover, Hannover, Germany

    H.-J. Schmoll M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag New York, Inc.

About this paper

Cite this paper

Wils, J.A. (1989). Advanced Gastric Cancer: Results of Chemotherapy Trials of the EORTC Gastrointestinal Group. In: Hotz, J., Meyer, HJ., Schmoll, HJ. (eds) Gastric Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3636-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3636-8_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-96955-8

  • Online ISBN: 978-1-4612-3636-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation